Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGFR1 known ✓ | P11362 | 5/20 | 0.54 |
| ▸ | EGFR known ✓ | P00533 | 1/20 | 0.49 |
| ▸ | SRC known ✓ | P12931 | 1/20 | 0.42 |
| ▸ | PI4KA | P42356 | 1/20 | 0.49 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.49 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.49 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | GAK | O14976 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL680855 | 0.98 | FGFR1 (0.56) | FGFR1EGFRPI4KAPI4K2BPI4K2A | |
| SCHEMBL3027720 | 0.85 | PI4KA (0.57) | FGFR1EGFRPI4KAPI4K2BPI4K2A | |
| SCHEMBL3697841 | 0.82 | MKNK2 (0.49) | FGFR1EGFRPI4KAPI4K2BPI4K2A | |
| SCHEMBL467133 | 0.81 | MKNK2 (0.47) | FGFR1EGFRPI4KAPI4K2BPI4K2A | |
| SCHEMBL30677290 | 0.77 | CYP1A2 (0.46) | FGFR1PI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL4542537 | 0.77 | POLB (0.54) | FGFR1HTTMKNK2CYP1A2ALDH1A1 | |
| SCHEMBL27560848 | 0.76 | CYP1A2 (0.41) | FGFR1MKNK2CYP1A2ALDH1A1CYP2C9 | |
| SCHEMBL1408354 | 0.76 | QPCT (0.47) | MKNK2CYP1A2ALDH1A1CYP2C9CYP3A4 | |
| SCHEMBL793846 | 0.76 | MKNK2 (0.48) | FGFR1PI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL6944930 | 0.76 | PI4KA (0.55) | FGFR1PI4KAPI4K2BPI4K2API4KB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090076019-A1 | METHODS FOR TREATING NEUROLOGICAL DISORDERS OR DAMAGE | MOUNT SINAI HOSPITAL (CA) | 2009-03-19 | — | — | US | disclosed |
| EP-0845989-B1 | PAIN-ALLEVIATING DRUG COMPOSITION | UNIV VIRGINIA COMMONWEALTH (US) | 2002-03-13 | — | — | EP | disclosed |
| US-5869498-A | ADMINISTERING A COMBINATION OF OXYCODONE, NAPROXEN AND A NONTOXIC N-METHYL-D-ASPARATATE (NMDA) RECEPTOR ANTAGONIST SUCH AS DEXTRORPHAN OR DEXTROMETHORPHAN | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 1999-02-09 | — | — | US | disclosed |
| US-5863922-A | AN ANALGESICS MIXTURE COMPRISING ACETAMINOPHEN, SEDATIVE BUTALBITAL AND A N-METHYL-D-ASPARTATE RECEPTOR ANTAGONIST SELECTED FROM DEXTRORPHAN, DEXTROMETHORPHAN | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 1999-01-26 | — | — | US | disclosed |
| US-5840731-A | COMPOSITION COMPRISING OPIOID ANALGESIC, ACETAMINOPHEN, NONTOXIC N-METHYL-D-ASPARTATE RECEPTOR ANTAGONIST | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 1998-11-24 | — | — | US | disclosed |
| EP-0845989-A2 | PAIN-ALLEVIATING DRUG COMPOSITION AND METHOD FOR ALLEVIATING PAIN | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 1998-06-10 | — | — | EP | disclosed |
| WO-1997004780-A2 | PAIN-ALLEVIATING DRUG COMPOSITION AND METHOD FOR ALLEVIATING PAIN | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 1997-02-13 | — | — | WO | disclosed |
| US-5188825-A | Water soluble active material bonded to ion exchange resin | R. P. SCHERER CORPORATION | 1993-02-23 | — | — | US | disclosed |
| EP-0219458-B1 | MEDICAMENT ADSORBATES AND THEIR PREPARATION | WARNER-LAMBERT COMPANY (US) | 1990-05-23 | — | — | EP | disclosed |
| US-4818539-A | EDIBLE MATRIX, PRE-SWELLED ANHYDROUS HYDROCOLLOID, DRUG OR DIETARY FIBER | WARNER-LAMBERT COMPANY (US) | 1989-04-04 | — | — | US | disclosed |
| US-4804548-A | AGGLOMERATED MIXTURE OF CORE AND MATRIX; LECITHIN, GLYCERIDE, FATTY ACID AND/OR WAX | WARNER-LAMBERT COMPANY (US) | 1989-02-14 | — | — | US | disclosed |